U.S. Single-use Bioprocessing Market: Industry Demand, Analysis and Future Trends 2030

[sara James]

The U.S. Single-Use Bioprocessing Market size was estimated at USD 9.34 billion in 2024 and is projected to grow at a CAGR of 15.04% from 2025 to 2030. Due to the high demand for biopharmaceuticals, suppliers have made their disposable product offerings more robust and inclusive. Single-use equipment suppliers are trying to fulfill end users' growing and ever-changing expectations.

The U.S. single-use bioprocessing industry experienced a positive impact from the COVID-19 pandemic, particularly due to the increased demand for single-use products driven by the heightened need for vaccines, treatments, and assays. These products played an important role in facilitating the rapid scaling up of production by biopharmaceutical companies to meet the unprecedented global demand for vaccines. The pandemic underscored the importance of maintaining sterility and minimizing contamination risks in pharmaceutical and biologics production, highlighting the significance of single-use products in such scenarios.

Key U.S. Single-use Bioprocessing Companies:

• Sartorius AG
• Danaher
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Avantor, Inc.
• Eppendorf SE
• Corning Incorporated
• Meissner Filtration Products, Inc.
• Lonza
• PBS Biotech, Inc.

Request a free sample copy or view report summary: U.S. Single-use Bioprocessing Market

U.S. Single-use Bioprocessing Market Report Highlights

• The simple & peripheral elements segment held the largest market share of 48.54% in 2024 due to continuous innovations in these products and the increasing prominence of bioprocessing operations in manufacturing.
• The upstream segment dominated the U.S. market with a share of 57.80% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period.
• In 2023, biopharmaceutical manufacturers held the largest market share in the end use segment and are anticipated to grow at the fastest CAGR over the forecast period.

Recent Development

• In August 2024, Freudenberg Medical expanded its biopharma portfolio with custom single-use assemblies, including Y-connector manifolds, tubing, and bottle cap assemblies, for critical fluid transfer in labs and CGMP bioprocesses.
• In July 2024, Qosina partnered with Polestar Technologies, experts in monitoring O2, CO2, and pH, and added Polestar's iDOT Single-Use Sensor Bag Ports to its product portfolio.
• In June 2023, Sartorius AG partnered with Waters Corporation to create integrated analytical solutions for downstream biomanufacturing, expanding their existing agreement.